Sarvotham: Reviving Indian Traditional Healthcare Through Nutraceuticals

Dopesh Raja, Director

Dopesh Raja

Director

The global nutraceutical market was valued at 396.29 billion in 2021 and is anticipated to grow at a CAGR of 5.2% between 2022 and 2030. The growing acceptance of medical nutrition due to increasing health-consciousness across the world is considered an impetus for the market growth. In countries like India, where people are struggling with illnesses aggravated by unhealthy lifestyle or health complications related to aging,nutraceutical aids are slowly making their way into the dietary habits as preventive healthcare measures.As people realize the benefitsof nutraceuticals, the demand for effectual products is rapidly increasing.

This is where Sarvotham stepped in and pledged to be a reliable companion for good health and nourishment with a wide spectrum of healthcare products that undergo stringent quality examinations to ensure the right product, first time, everytime. Sarvotham specializes in the manufacture of a wide range of healthcare products for several multinational companies. It capitalizes on the power of innovation and its state-of-the-art manufacturing facilities in order to cater to the changing consumer preferences for nutraceutical products. Pharma Industry Outlook engaged in a conversation with Dopesh Raja, Director of Sarvotham Limited, in order to know more about its offerings and the core philosophies it is governed by.

Give us an overview ofthe current opportunities in the nutraceutical market. How has it been developing over the years and what are the major factors driving growth in nutraceutical segment?

The nutraceutical industry has grown since the revolution in 2016 when new regulations were introduced to the Indian and global markets. India has seen the evolution of good quality manufacturers, transformation of the pharmaceutical industry by adopting nutraceuticals in their portfolio and a rise in the start-up world with strong innovations. We can see that India slowly but clearly progressing to evolve as a strong and responsible nutrition hub in the international sphere. An industry that was growing steadily in predictable trends took a quantum jump and the entire ecosystem is shining with active government incentives, more R&D activities, clinical studies on nutraceuticals and market expansion due to demanding health situation induced by pandemic and greater consumer awareness. Industry is expected to Grow at a compounded Annual Growth Rate (CAGR ) of 8.9% from 2020 to 2028 and the major factors that have been driving the market growth are government initiatives, international transactions and the most importantly the consciousness of the consumers and the manufacturers to process in global quality compliant.

What are the major expectations when a prospective client comes up to you and how do you think you have been meeting those expectations?

As far as health and nutrition is concerned, quality and efficacy are two common asks of the consumer along with cost-friendliness. Being an eminent customized manufacturing organization, we had invested different types of resources to meet the cGMP standards of various countries, the Global Halal, NSF & ISO standards to name a few. We are constantly upgrading our facilities, training our team and evolving our systems to adapt to the latest regulatory requirements. Our Agasthya Centre of Excellence in Hyderabad is an ultra modern facility equipped with modern technology to ensure that we meet or exceed the global guidelines of nutraceuticals much more ahead, at par with the pharmaceutical norms, in terms of quality, delivery and innovation. Sarvotham is well poised to cater to all such emerging needs.

Give us a brief overview of the company as well as the organization as a whole. How is it positioned in the segment today?

Sarvotham was established in 1996, as a manufacturer of world class products in the Health, Personal & Home care products. With its first facility in Hyderabad, Sarvotham catered to the demanding needs of marquee clients of international repute. The world class facilities in Baddi, Himachal Pradesh with large volume, high speed and automated manufacturing lines cater to the needs of global clientele, producing multiple formats like liquids, gels, lotions, tablets, capsules and powders.

The fully integrated Centre of Excellence that has been recently inagurated in Hyderabad carries out customized R&D in novel formatslike gummies, chews, orally dissolving strips, tablets, liquid filled capsules etc., in addition to conventional formats. We have also established CROs as independent entities to cater to the global regulatory needs in Toxicology and Human clinical trials.Sarvothamstands at a different pedestal in providing comprehensive to provide to clients with comprehensive solutions starting from concept designing, drug discovery, preclinical clinical publication, licensing to manufacturing.

Tell us about any unique range of services that the company is known for in the market. Please highlight the USPs of the same.

Sarvotham is well known in the industry circles for its Integrity, Transparency and Solutioning. We have successfully completed several projects of concept to commercialization for our marquee clients, not only in the Indian market but also in the international market space. Some of our signature product concepts include bi-layered gummies, multi-layered bars, orally dissolving strips / tablets using nano molecule actives for rapid absorption etc. In addition, our scientists have also developed several products in the health care & personal care categories, using natural ingredients and processing then to enhance the power of Mother Nature.

Products for enhancing immunity, anti-inflammatories, pain management and beauty enhancers are a few of the novel concepts being actively worked on by our highly competent scientists, to help the growing nutraceutical needs of the country.

What has been the success mantra, and the approach of the company in maintaining strict quality standard?

Our mantra is simple “RIGHT FIRST TIME EVERY TIME". Our products are made to meet global quality standard and we release products which are 100% compliant to all the regulatory guidelines we abide by.

Sarvotham has been partnering with companies of international repute, almost from inception. As a result our team has been exposed to stringent international quality and regulatory environments. This, coupled with our hunger to learn has led to our continual improvement of systems and procedures in line with international regulatory guidelines. Sarvotham’s facilities have several quality accreditions like ISO 9001(2000), EMS 14000(2004), GMP & Schedule M(FDA India), WHO-GMP, NSF etc. to name a few. The quality managemtent systems ensure that each process right from Concept to Commercialization is geared towards a truly Sarvotham product.

Where do you see the company in the near future? What might be the expansion plans?

There is a substantial amount of awareness that is coming about in the consumers from the perspective of preventive approach towards their health rather than a curative approach. The greater awareness results into greater consumption of nutraceuticals or dietary supplements. What we are doing is carrying out research based on the ancient principles of Ayurvedaand refining these principles and working on the development of products to meet not just the domestic regulatory requirements, but the international standards as well.

The format of the product too plays a major role in the aceptability of the product by the consumers, be it children, adults or the senior citizens. We are actively working on formulating active ingredients into novel formats like gummies, bars, orally dissolving strips etc., to not only increse the ease of use, but also the to boost the efficiay of the products.

on the deck


Most Viewed

Addressing Antimicrobial Resistance (AMR) Through Collaborative Efforts Fostering a Quality Culture in the Pharmaceutical Industry Advancements in Computer-Aided Drug Design for Pharmaceutical Research Why India is Gaining Popularity for Clinical Trials The Future of Kidney Transplants in India Usage of Conversational AI in the Health Insurance Sector Strategies for India to Reduce Its API Dependence on China Business Impact of USFDA Approvals on Indian Pharma Companies Innovative Strategies for Expanding Access to Life Saving Healthcare Solutions Badhal Village Crisis: How Rapid Diagnostics Could Have Saved Lives Why India is a Hotspot for Biotech Startups? Why Adapting Flexibility in IP Rights will Drive Generics Market Meeting the Challenges of High-Potency API (HPAPI) Production Impact of Human Factors Engineering on Medical Device Safety The Future of Pharma: Embracing Continuous Manufacturing The Role of Orphan Drugs in Treating Rare Diseases Emerging Technologies Shaping the Future of Drug Formulation Strategies for Optimizing Pharmaceutical Supply Chain Efficiency The Future of Medicine: Harnessing the Power of RNA-based Therapeutics AI in Medicine: Unmasking the Myths and Embracing the Transformative Reality Cycle Pharma Acquires Banner Life Sciences WHO's First-ever Global Summit on Traditional Medicine Starts in Gujarat The Importance of Data Integrity in Pharmaceutical Quality Control DCGI in Talks with Stakeholders to Develop a Standardised Web Platform to Assure Drug Quality and Patient Safety Glenmark Pharmaceuticals secures ANDA Nod for 0.03 per cent Tacrolimus Ointment Streamlining Laboratory Operations with a Modern LIMS Healthtech Start-up Suraksha QR Ropes In Actor Murali Sharma as its Brand Ambassador Unlocking the Potential of Pharmacogenomics: Enhancing Drug Safety and Efficacy The Impact of Pharmaceutical Testing on Drug Development India has Identified Three Health Priorities to Strengthen Global Health Infrastructure, says WHO National Health Authority launches 100 Microsites Project to Speed Up Digital Health Adoption India Should Partner with Australia to avail PBS for the Selection, Listing, and Pricing processes of exported drugs, says Sudarshan Jain Zydus Lifesciences India More than Doubles Profit Due to Increased Sales in the US India Triples Organ Donations over Past Decade says Union health minister Mansukh Mandaviya Advent Therapeutics Awarded $3 Million NIH Grant For Novel Neonatal Lung Therapy Three Pharma Marketing Strategies That Drive Sales Novartis Targets India's Rare Disease Market with 17 Clinical Programs UK Health Regulator approves GSK's Vaccine for the common respiratory virus RSV WHO Urges Increased Use Of Recommended Malaria-Fighting Tools Karnataka Budget Offered a Significant Boost to Health & Lifesciences Start-ups with Focus on Infrastructure & Innovation Three High Potential Moonshot Project Areas in Pharma CCI approves Bharat Biotech International-Eastman Exports deal How Biotech is Revolutionizing the Fight Against Cancer LifeCell and HaystackAnalytics ink strategic pact to scale-up TB whole genome sequencing pan-India Mankind Pharma IPO To Open On April 25 With A Price Fixed At Rs 1,026-1,080 Per Share US CDC Approves Second Omicron-Updated COVID Booster For Adults Three Trends that will Impact Pharmaceutical Industry in 2023 ModeX Therapeutics Commences Phase I EBV Vaccine Trial with Merck Designing Impactful Leadership and Talent Management Programs with Strategies for Success Novo Nordisk and Valo Health Partner to develop novel Treatments FOPE Calls for Extended Deadline for Schedule M Compliance Telix Pharma To Acquire ImaginAb to Boost Therapeutics and Innovation Roche Secures US FDA Approval for its Ultra-Sensitive ISH test Rappta Therapeutics and SpringWorks Partner on Molecular Glue Targeting PP2A Taro Pharma To Acquire entire stake in Antibe Therapeutics Innovent Biologics Secures Breakthrough Therapy Designation for IBI343 Emcure Pharma Launches Largest R&D Centre in Ahmedabad Zydus Bags USFDA Nod for Phase II(b) Trial to Optimize Usnoflast Dosage US FDA Approves Amgen's Lumakras-Vectibix Combo for KRAS G12C-Mutated mCRC Glenmark Pharma Unveils generic anticoagulant injectable emulsion Strides Pharma Bags USFDA Nod for OTC Acetaminophen-Ibuprofen Combo Tablets US FDA Lifts Hold on Sanofi's Trial to Make Cialis Available Over-the-Counter Hoth Therapeutics Expands Intellectual Property with New Patents Jaguar Health Starts POC Trial of Crofelemer for Rare Pediatric Disease MVID Pharma and Healthcare Sector Eyes Union Budget 2025 for Innovation Boost How Innovative Drug Formulations are Enhancing Treatment Outcomes Apollo and Mayapada Healthcare Unite to Boost Indonesia's Healthcare Novo Nordisk Reports Positive Phase 1b/2a Results for Amycretin Govt to Extend Schedule M Compliance Deadline for Drug Manufacturers to Dec Lupin Secures US FDA Nod for Ipratropium Bromide Nasal Solution ANDA Granules Pharmaceuticals Secures USFDA Nod for Key Generic Drug Bajaj Healthcare Bags DCGI Nod to Manufacture Pimavanserin API & Formulation Union Budget 2025: Healthcare Gets 9.78% Boost, Allocation Nears 1 Lakh Crore Metropolis & Roche Launch Self-Sampling HPV Test for Cervical Cancer Sigachi Industries Invests $1M in Hyderabad R&D Hub for API Innovation Pharma Testing Market Surges with Rising Demand for Biologics ISTH Releases Clinical Practice Guideline For Haemophilia Treatment Sanofi and Biovac Lead Polio Vaccine Manufacturing Capabilities Sun Pharma and Takeda Ink Pact To Market Gastrointestinal Drug Takeda and Ascentage Pharma Ink Option Agreement For Olverembatinib Enhancing Compliance through Effective Pharmaceutical Regulatory Affairs Strategies India poised to become a Global Hub for Clinical Trials: Exec SCHOTT Pharma Unveils Next-Gen Polymer Syringes for Enhanced Safety GSK's Jemperli Gains EU Nod for First-Line Treatment of Endometrial Cancer Union Health Secretary Urges Stronger Drug Regulations for Quality Control Telangana Govt Inks Landmark Deals to Propel Life Sciences and Job Growth R&D in Indian Pharma: Breakthroughs and Innovations in 2024 Dr. Reddy's Partners with Shanghai Henlius to Develop Cancer Drug Uniphar Expands Global Footprint with Three New Facilities 74th Indian Pharmaceutical Congress 2025 Opens Registrations AGC Pharma Expands HPAPI Capabilities in Barcelona to Meet Growing Demand The Future of Genomic Sequencing: Trends That Will Define the Next Decade Lexaria Bioscience Ethics Review Board Nod to Commence New GLP-1 Study Amitabh Kant Urges India to Focus on Innovation at BioAsia 2025 Government Enhances Research & Integration Initiatives in Unani Medicine Blind & Deaf individuals face Major Barriers to access Medicines: Report C-CAMP and PariSante Campus launched Indo-French Life Sciences Hub Jaguar Health Begins Pediatric Trial for Crofelemer in Short Bowel Syndrome Algiax Pharma Reports Promising Phase 2a Results for AP-325 Govt Bans 34 Antimicrobials for Use in Animals Pharmaceutical Procurement Strategies: How to Optimize Costs Personalized Medicine: Get Tailored Treatment Plans for You Now How to Bridge the Healthcare Gap in Emerging Markets with MedTech The Evolution of In-Vitro Diagnostics: Trends and Future Prospects Needle-Free Injection System: A Game Changer in Less Pain Vaccination How Global Capability Centers are Shaping the Future of Biometrics Building a Successful Pharma Brand in India: The Role of Scientific Communication Unlocking India's Innovation Potential in Pharma The Future of Green Chemistry in API Production Top 10 Pharmaceutical Recruitment Consultants - 2024 | Pharma Outlook Blockchain for Secure Pharmaceutical Supply Chains - 2025 & Beyond Mass Spectrometry in Biomarker Discovery for Early Disease Detection Iconovo and Lonza Team up to Advance Intranasal Biologic with ICOone Nasal Fetal Imaging to Cardiac Diagnosis: The Expanding Role of Ultrasound Balancing Innovation and Affordability in Medical Solutions for India Changing Landscape for LTBI and Syndromic Testing Methodologies How Advanced Training Methods can Enhance Patient Care Balancing Cost Efficiency and Compliance in Pharmaceutical Manufacturing LUB Urges Govt to Scrap Mandatory Lab Testing for Cough Syrup Exports Role of Optical Imaging in Early Cancer Detection and Treatment Hoth Therapeutics Unveils Promising Data for KIT-Targeting Therapy Pharmexcil Engages ASEAN Nations to Boost Pharma Trade Ties Fortis Partners with Teleflex for South Asia UroLift Training Anti-Infectives: How New Research is Shaping Infection Control Building Bridges for Sustainable Growth through Strategic Alliances in Ethical Pharmaceuticals Quality as the Cornerstone of Lab Solutions FDA Approves Roch's NSCLC Diagnostic Linked to Emrelis How Early Detection is Transforming Cancer Treatment in India Ensuring Data Privacy in Pharma World Enhancing Clinical Trial Supply Chain Resilience to Address Global Disruptions in India Cost-Effectiveness of Minimally Invasive Surgery in Outpatient Settings How Organic Synthesis is Accelerating Drug Discovery in Pharma Strategic finance for pharmaceutical innovation and stability Top 10 Teleradiology Service Providers - 2024 | Pharma Outlook Importance of Investing in R&D and Quality for Competitive Advantage in Eye Care Top 10 In Vitro Diagnostics Companies - 2024 | Pharma Outlook Phytopharmaceuticals: Driving Global Herbal Medicine Innovation Gender Gap in Healthcare: Why Women's Health Needs More Research Impact of Modern Technology on the Indian Life Sciences Sector Why Global Pharma Expects CDMOs to Be Ready for Joint Inspections The Role of Customizable Stent Grafts for Treating Complex Anatomies Nutraceuticals vs Pharmaceuticals: Complementary or Alternative in Chronic Disease Management? Top 10 Pharma CDMO Companies In India – 2023 | Pharma Outlook Leaping Towards Global Compliance with Revised Schedule M Meril Concludes TechVentory, Boosts AI-Driven Healthcare Supply Chains 10 Pharma Sector Revolutions in India Standardizing Medicine Labeling and Embracing Digital Transformation Creating a patient-centric healthcare ecosystem for all Biomanufacturing of Enzymes: A Sustainable Approach to Industrial Biotechnology Integrating CSR into HR Practices to Enhance Brand Reputation in Pharma Merck Launches Phase 3 Trial for Promising Dengue Vaccine V181 Breakthrough: Eye-Opening Healthcare Strategies Doctors Swear By on Doctor's Day 2025 Bristol Myers Squibb Reports Strong Phase 3 Results for Deucravacitinib trail Alcon Launches Innovative Daily Lenses Designed for Long-lasting Comfort Apisolex Excipient by Lubrizol Backs Phase I Drug Success FDA Approves Enflonsia to Prevent RSV in Infants with One Dose Biosimilars in India 2025 Market Trends, Growth Forecast & Opportunities How Regulations Are Shaping India's Medical Device Landscape Bharat Biotech Partners with GSK for Shigella Vaccine Development Eli Lilly Obesity Drug Shows 11.5% Weight Loss in 12 Weeks Laborate Pharmaceuticals: Illuminating Pathways Of Quality, Affordability Innovation In Healthcare Sun Pharma Bags CDSCO Approval to Produce Fexuprazan Hydrochloride Tablets The Fusion of Biology, Medicine, Health, and AI Glenmark Gets DCGI Nod to Launch Oncology Drug BRUKINSA in India Kyndryl Partners with Dr Reddys to Automate Global IT Operations How Robotic Assisted Surgery Is Redefining Precision in Kidney Transplants Top 10 Women Disruptors in Asia Pharmaceutical Industry

Editor's Guest


© 2025 India Pharma Outlook. All Rights Reserved.